Document:

Exhibit
10.29

 

Promissory
Note

 

This
Note shall only become effective upon the consummation of an initial public
offering of the Maker (as defined below) and until such time shall be of no
force or effect.  Upon the consummation
of such initial public offering, a certain Inter-Company Note of Maker dated September 30,
2009 in the aggregate principal amount of $10,000,000 in such actual amount as
shall have been advanced at such time shall be deemed to have been terminated
and replaced in its entirety by this Note. 
However, unless and until the consummation of such initial public
offering, said Inter-Company Note shall remain in full force and effect.

 

For value received, the undersigned, Bruker Energy & Supercon
Technologies, Inc. (“Maker”) promises to pay to the order of Bruker
BioSpin Corporation (“Lender”), at its principal office, effective upon
completion of the Maker’s initial public offering, an aggregate principal
amount equal to the amount outstanding under said Inter-Company Note as of the
date of the closing of said initial public offering, such aggregate principal
amount to be paid in twelve (12) equal quarterly installments commencing with
the end of the Interest Period in which falls the day one hundred eighty (180)
days after the closing of said initial public offering and continuing at the
end of each Interest Period thereafter.

 

Maker also promises to pay interest on the principal
amount hereof as outstanding during each Interest Period at a rate per annum
equal to five percent (5%).  Such interest
shall be computed on the basis of a 360-day year and actual days elapsed during each Interest
Period.

 

“Interest
Period” shall mean the three-month periods ending on  December 31st, March 31st,  June 30th, and  September 30th; provided, however, that the
first Interest Period shall be the period
commencing on the closing of said initial
public offering and ending on the
last day of the Interest Period in which such closing date falls; further provided
that if any Interest Period would
otherwise end on a  day which is not a Business Day, such Interest Period shall end on the first preceding Business Day.

 

If payment of interest on this Note is subject to withholding taxes by
any government or governmental instrumentality, then the amount of interest
payable to Lender hereunder shall be reduced by the amount of such
withholdings.  However, in this event, Maker shall be obliged to provide tax
withholding certificates to Lender
evidencing such tax deductions.

 

The term  “Business Day” shall mean a day when banks are open for business in Massachusetts.

 

Maker may, at its
option, pay all or any part of the Loan, without penalty or premium, provided that on each payment the undersigned shall pay accrued interest on the principal amount being paid to the date of payment.

 

Presentment, demand, notice and protest in connection with any default under or enforcement of this Note are hereby waived by Maker.  Maker agrees to
pay all costs and expenses (including reasonable attorney’s fees) incurred by
or paid by Lender (or other holder hereof) in enforcing this Note upon default.

 

 

This Note and borrowing hereunder shall be construed, interpreted and
governed in all respects in accordance with the laws of Massachusetts.

 

IN WITNESS WHEREOF, Maker has caused this Note to be signed by its duly authorized officer.

 

 

Bruker Energy & Supercon Technologies, Inc. (“Maker”)

 

 

	
  By:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Title :

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  
	
  Accepted :

  	
   

  
	
   

  	
   

  
	
  Bruker BioSpin Corporation (“Lender”)

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Title:Exhibit
10.30

 

Intercompany Loan Agreement

 

between

 

Bruker BioSpin GmbH

Silberstreifen 4,

76287 Rheinstetten

 

as Lender

 

and

 

Bruker EAS GmbH

Ehrichstrasse 10,

63450 Hanau

 

as Borrower

 

1.             The Loan

 

1.1           The Lender agrees to grant to the
Borrower until further notice a credit line in the amount of EUR 1.500.000,00
(EUR One Million Five hundred Thousand).

 

1.2           The payment can be executed in total
or in partial amounts up to the nominal amount until prior written notice.

 

1.3           The obligation of the Borrower to
repay the Loan and/or interest according to this agreement is subject to the
condition that such payments do not cause a short fall of the net assets of the
Borrower below the amount of the stated capital protected pursuant to §§ 30, 31
German Act on Limited Liability Companies (GmbHG) or any increase of an
existing shortfall below such amount. To the extent the Borrower can capitalize
hidden reserves by selling assets and thereby prevent an infringement of the
net assets required to maintain the stated capital, it shall be obliged to sell
such assets at its choice; any assets required for the business as a going
concern shall however be released from this obligation.

 

2.             Interest

 

2.1           Interest shall be computed on the
basis of the actual number of days elapsed in a 360-day-year. The interest rate
is equal to 3.5% p. a..

 

2.2           Any interest shall become due and
payable at the end of each quarter.

 

3.             Repayment

 

The
repayment of the loan in the amount of the actual borrowing will be due on June 30th of each calendar year.

 

 

4.             Optional Repayments

 

The
Borrower shall be entitled to repay the Loan at all times without premium or
penalty upon prior written notice to the Lender, either in whole or in part.

 

5.             Securities

 

The
Loan is secured by a Comfort Letter of Bruker Corporation, Billerica/USA
providing the borrower with sufficient financial support to continue trading as
a going concern and to discharge its debt and liabilities as they fall due.

 

Dated:    September 7, 2009

 

 

	
  Bruker
  EAS GmbH

  	
   

  	
  Bruker
  BioSpin GmbH

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  /s/
  Burkhard Prause /s/ Peter Unvericht

  	
   

  	
  /s/
  Bernd Geweise /s/ Joerg Laukien

  

 

2

 

	
   

  	
  Bruker
  Corporation

  
	
   

  	
  40
  Manning Road

  
	
   

  	
  Billerica,
  MA 01821 USA

  
	
   

  	
   

  
	
   

  	
  978-663-X1122
  phone

  
	
   

  	
  978-667-2917
  fax

  
	
   

  	
  www.bruker.com

  

 

William J. Knight

Chief
Financial Officer

 

September 3,
2009

 

Dear
Sirs,

 

We
will provide Bruker EAS GmbH with sufficient financial support to enable it to:

 

Continue
trading as a going concern;

 

Discharge
its debts and liabilities as they fall due

 

We
intend to provide such sufficient financial support to enable the company to
trade and to discharge its debts and liabilities until December 31st, 2010.

 

	
  Sincerely,

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  /s/
  William Knight

  	
   

  
	
  William
  J. Knight

  	
   

  
	
  Chief
  Financial Officer

  	
   

  

 

3Exhibit 10.31

 

Intercompany Loan Agreement

 

between

 

Bruker BioSpin GmbH

Silberstreifen 4,

76287 Rheinstetten

 

as Lender

 

and

 

Bruker HTS GmbH

Ehrichstrasse 10,

63450 Hanau

 

as Borrower

 

1.                                      The
Loan

 

1.1                                 The Lender
agrees to grant to the Borrower until further notice a credit line in the
amount of EUR 5.500.000,00 (EUR Five Million Five hundred Thousand).

 

1.2                                 The payment can
be executed in total or in partial amounts up to the nominal amount until prior
written notice.

 

1.3                                 The obligation
of the Borrower to repay the Loan and/or interest according to this agreement
is subject to the condition that such payments do not cause a short fall of the
net assets of the Borrower below the amount of the stated capital protected
pursuant to §§ 30, 31 German Act on Limited Liability Companies (GmbHG) or any
increase of an existing shortfall below such amount. To the extent the Borrower
can capitalize hidden reserves by selling assets and thereby prevent an
infringement of the net assets required to maintain the stated capital, it
shall be obliged to sell such assets at its choice; any assets required for the
business as a going concern shall however be released from this obligation.

 

2.                                      Interest

 

2.1                                 Interest shall
be computed on the basis of the actual number of days elapsed in a
360-day-year. The interest rate is equal to 3.5% p. a..

 

2.2                                 Any interest
shall become due and payable at the end of each quarter.

 

3.                                      Repayment

 

The
repayment of the loan in the amount of the actual borrowing will be due on June 30th of each calendar year.

 

 

4.                                      Optional
Repayments

 

The
Borrower shall be entitled to repay the Loan at all times without premium or
penalty upon prior written notice to the Lender, either in whole or in part.

 

5.                                      Securities

 

The
Loan is secured by a Comfort Letter of Bruker Corporation, Billerica/USA
providing the borrower with sufficient financial support to continue trading as
a going concern and to discharge its debt and liabilities as they fall due.

 

	
  Dated:  September 7, 2009

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Bruker
  HTS GmbH

  	
   

  	
  Bruker
  BioSpin GmbH

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  /s/
  Burkhard Prause /s/ Peter Unvericht

  	
   

  	
  /s/ Bernd Geweise /s/ Joerg Laukien

  

 

2

 

Bruker
Corporation

40
Manning Road

Billerica,
MA 01821  USA

 

978-663-X1122
phone

978-667-2917
fax

www.bruker.com

 

William J. Knight

Chief
Financial Officer

 

September 3,
2009

 

Dear
Sirs,

 

We
will provide Bruker HTS GmbH with sufficient financial support to enable it to:

 

Continue
trading as a going concern;

 

Discharge
its debts and liabilities as they fall due

 

We
intend to provide such sufficient financial support to enable the company to
trade and to discharge its debts and liabilities until December 31st, 2010.

 

	
  Sincerely,

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  /s/
  William Knight

  	
   

  
	
  William
  J. Knight

  	
   

  
	
  Chief
  Financial Officer

  	
   

  

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]